Bausch & Lomb (Australia) Pty Ltd

Regulatory activities for this sponsor.

3 result(s) found, displaying 1 to 3

AusPAR: Loteprednol etabonate

17 April 2014

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Loteprednol etabonate
AusPAR: Besifloxacin hydrochloride

3 February 2014

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Besifloxacin hydrochloride
Lubricant, eye [44237] (Cancelled under s.41GN(1)(c))

1 October 2013

Cancellation or suspension

Regulatory action due to As the sponsor of the kind of medical device failed to comply with the notice under s.41JA of the Act, requesting the sponsor to give the TGA information relating to the kind of device, within a further 10 working days from the day specified in the notice, the entry was cancelled., effective 01/10/2013